Microbix Biosystems Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.06 |
Market Cap |
$20.03 M |
Shares Outstanding |
96.77 M |
Public Float |
- |
Microbix Biosystems Inc. | |
Stock Exchange | Toronto Stock Exchange Prices |
EPS |
CAD0.08 |
Market Cap |
CAD26.67 M |
Shares Outstanding |
96.97 M |
Public Float |
80.66 M |
Address |
265 Watline Avenue Mississauga Ontario L4Z 1P3 Canada |
Employees | - |
Website | http://www.microbix.com |
Updated | 07/08/2019 |
Microbix Biosystems, Inc. engages in the manufacture of viral and bacterial antigens and reagents for the global diagnostics industry. Its biological solutions include products for human health applications in the vaccine, therapeutic and diagnostic markets, and a product for the worldwide animal reproduction market. Its pipeline of technologies and products include LumiSort, semen sexing technology for the livestock industries; and Kinlytic, a thrombolytic drug for life-threatening blood clots. |